Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

4.09
Delayed Data
As of Aug 23
 +0.11 / +2.76%
Today’s Change
2.06
Today|||52-Week Range
5.18
+61.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization97.0K106.0K87.0K77.0K
 
 
 
 
 
 
Operating ExpensesGross Income-97.0K-106.0K-87.0K-77.0K
 
 
 
 
 
General Expenses4.9M7.3M8.4M5.0M
 
 
 
 
 
Research And Development2.9M4.8M4.9M2.3M
 
 
 
 
 
Total Operating Expenses5.0M7.4M8.5M5.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.0M-7.4M-8.5M-5.1M
 
 
 
 
 
Other Expenses0.00-1.8M0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.9M-9.2M-8.5M-5.0M
 
 
 
 
 
Income Taxes-25.0K0.000.000.00
 
 
Net Income-4.9M-9.2M-8.5M-5.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.7M13.7M18.4M18.7M
 
 
 
 
 
Shares To Calculate EPS Diluted10.7M13.7M18.4M18.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.45-$0.68-$0.46-$0.27
 
 
 
 
 
EPS Diluted-$0.45-$0.68-$0.46-$0.27